Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Fleseriu · SciRah

Researcher profile · Semantic Scholar

M. Fleseriu

Share profile

M. Fleseriu — researcher profile on SciRah

h-index: 54
Works: 370
Citations: 12K

Most-cited papers

Consensus on Diagnosis and Management of Cushing’s Disease: A Guideline Update
M. Fleseriu, R. Auchus, I. Bancos, Anat Ben-Shlomo +49 more
2021The Lancet Diabetes and Endocrinology702 citations Open access
Semantic Scholar
Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement
S. Petersenn, M. Fleseriu, F. Casanueva, A. Giustina +32 more
2023Nature Reviews Endocrinology369 citations Open access
Semantic Scholar
Clinical Biology of the Pituitary Adenoma
S. Melmed, U. Kaiser, M. Lopes, J. Bertherat +9 more
2022Endocrine reviews284 citations Open access
Semantic Scholar
Cushing Syndrome: A Review.
M. Reincke, M. Fleseriu
2023Journal of the American Medical Association (JAMA)197 citations
Semantic Scholar
Acromegaly: pathogenesis, diagnosis, and management.
M. Fleseriu, F. Langlois, D. Lim, E. Varlamov +1 more
2022The Lancet Diabetes and Endocrinology155 citations
Semantic Scholar
Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline
E. Husebye, F. Castinetti, S. Criseno, G. Curigliano +8 more
2022European Journal of Endocrinology149 citations Open access
Semantic Scholar
An individualized approach to the management of Cushing disease
M. Fleseriu, E. Varlamov, J. M. Hinojosa-Amaya, F. Langlois +1 more
2023Nature Reviews Endocrinology58 citations
Semantic Scholar
Long-term outcomes of osilodrostat in Cushing’s disease: LINC 3 study extension
M. Fleseriu, J. Newell-Price, R. Pivonello, A. Shimatsu +11 more
2022European Journal of Endocrinology45 citations Open access
Semantic Scholar
Updates in adrenal steroidogenesis inhibitors for Cushing's syndrome - A practical guide.
E. Varlamov, A. J. Han, M. Fleseriu
2021Best practice & research. Clinical endocrinology & metabolism44 citations
Semantic Scholar
Dynamic testing for differential diagnosis of ACTH-dependent Cushing Syndrome: a systematic review and meta-analysis.
F. Ceccato, M. Barbot, A. Mondin, M. Boscaro +2 more
2022Journal of Clinical Endocrinology and Metabolism38 citations Open access
Semantic Scholar
Treatment of Cushing’s syndrome with osilodrostat: practical applications of recent studies with case examples
M. Fleseriu, B. Biller
2022Pituitary37 citations Open access
Semantic Scholar
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States
M. Fleseriu, A. Barkan, M. Del Pilar Schneider, Yannis Darhi +5 more
2022Pituitary33 citations Open access
Semantic Scholar
Perioperative Management of a Patient With Cushing Disease
E. Varlamov, G. Vila, M. Fleseriu
2022Journal of the Endocrine Society32 citations Open access
Semantic Scholar
Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands
M. Fleseriu, M. Molitch, A. Dreval, N. Biermasz +6 more
2021Frontiers in Endocrinology32 citations Open access
Semantic Scholar
Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS)
R. Pivonello, S. Zacharieva, A. Elenkova, Miklós Tóth +8 more
2022Pituitary30 citations Open access
Semantic Scholar
Pituitary and SARS CoV-2: An unremitting conundrum
C. Capatina, C. Poiana, M. Fleseriu
2023Best practice & research. Clinical endocrinology & metabolism28 citations Open access
Semantic Scholar
Long-term efficacy and safety of osilodrostat in Cushing’s disease: final results from a Phase II study with an optional extension phase (LINC 2)
M. Fleseriu, B. Biller, J. Bertherat, J. Young +6 more
2022Pituitary28 citations Open access
Semantic Scholar
Personalized Medical Treatment in Patients with Acromegaly: A Review.
Dawn Shao Ting Lim, M. Fleseriu
2022Endocrine Practice27 citations
Semantic Scholar
Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era
A. Giustina, E. Legg, B. Cesana, S. Frara +2 more
2021Endocrine24 citations Open access
Semantic Scholar
Levoketoconazole treatment in endogenous Cushing’s syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes
M. Fleseriu, R. Auchus, Y. Greenman, S. Zacharieva +9 more
2022European Journal of Endocrinology21 citations Open access
Semantic Scholar
Osilodrostat treatment in patients with Cushing’s disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4)
A. Shimatsu, B. Biller, M. Fleseriu, R. Pivonello +9 more
2024Endocrine journal17 citations Open access
Semantic Scholar
Clinical features and complications of acromegaly at diagnosis are not all the same: data from two large referral centers
E. Varlamov, D. Niculescu, S. Banskota, S. Găloiu +2 more
2021Endocrine Connections17 citations Open access
Semantic Scholar
MPOWERED Trial Open-Label Extension: Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly
M. Fleseriu, M. Molitch, A. Dreval, Yulia G. Pokramovich +8 more
2023Journal of Clinical Endocrinology and Metabolism15 citations Open access
Semantic Scholar
Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies
M. Fleseriu, R. Pivonello, J. Newell-Price, Mônica R. Gadelha +9 more
2025Pituitary14 citations Open access
Semantic Scholar
Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing’s disease
R. Feelders, M. Fleseriu, P. Kadıoğlu, M. Bex +9 more
2023Frontiers in Endocrinology14 citations Open access
Semantic Scholar
Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience
R. Salvatori, P. Maffei, S. Webb, T. Brue +5 more
2022Pituitary14 citations
Semantic Scholar
Pituitary Disorders and COVID-19, Reimagining Care: The Pandemic A Year and Counting
M. Fleseriu
2021Frontiers in Endocrinology14 citations Open access
Semantic Scholar
Treatment Patterns, Adherence, Persistence, and Health Care Resource Utilization in Acromegaly: A Real-World Analysis
M. Fleseriu, Ariel Barkan, T. Brue, Edouard Duquesne +4 more
2023Journal of the Endocrine Society13 citations Open access
Semantic Scholar
Adult Growth Hormone Deficiency: Diagnostic and Treatment Journeys From the Patients’ Perspective
A. Hoffman, Tracy Mathison, Deno Andrews, Kristine Murray +2 more
2022Journal of the Endocrine Society11 citations Open access
Semantic Scholar
Clinical Study and Systematic Review of Pituitary Microadenomas vs. Macroadenomas in Cushing’s Disease: Does Size Matter?
A. Akirov, I. Shimon, M. Fleseriu, I. Dotan +7 more
2022Journal of Clinical Medicine11 citations Open access
Semantic Scholar
Durable biochemical response and safety with oral octreotide capsules in acromegaly
S. Samson, L. Nachtigall, M. Fleseriu, M. Jensterle +11 more
2022European Journal of Endocrinology11 citations Open access
Semantic Scholar
Medical treatment of functional pituitary adenomas, trials and tribulations
C. Capatina, F. Hanzu, J. M. Hinojosa-Amaya, M. Fleseriu
2024Journal of Neuro-Oncology8 citations
Semantic Scholar
Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement
S. Petersenn, M. Fleseriu, F. Casanueva, A. Giustina +32 more
2023Nature Reviews Endocrinology8 citations Open access
Semantic Scholar
Conundrums of Diagnosis and Management of Cushing's Syndrome in Pregnancy.
Monica Livia Gheorghiu, M. Fleseriu
2024Endocrinology and metabolism clinics of North America (Print)7 citations
Semantic Scholar
Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims Database
Kevin C. J. Yuen, A. C. Birkegård, L. Blevins, D. Clemmons +5 more
2022International Journal of Endocrinology7 citations Open access
Semantic Scholar
Cushing’s syndrome in women: age-related differences in etiology and clinical picture
A. Akirov, Laura Dery, M. Fleseriu, Yaron Rudman +8 more
2022Pituitary7 citations
Semantic Scholar
Acromegaly complications: an update
A. Giustina, M. Fleseriu
2026Journal of Clinical Endocrinology and Metabolism5 citations Open access
Semantic Scholar
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin?
S. Chiloiro, A. Giampietro, A. Bianchi, S. Menotti +10 more
2023Journal of Personalized Medicine5 citations Open access
Semantic Scholar
Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing’s Syndrome (LOGICS): Results From a Double-Blind, Placebo-Controlled, Randomized Withdrawal Study
S. Zacharieva, R. Pivonello, A. Elenkova, M. Tóth +8 more
2021Journal of the Endocrine Society5 citations Open access
Semantic Scholar
Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence - Authors' reply.
M. Fleseriu, F. Castinetti, M. Gadelha, A. Giustina +6 more
2022The Lancet Diabetes and Endocrinology4 citations Open access
Semantic Scholar
A Phase 3 Large International Noninferiority Trial (MPOWERED): Assessing Maintenance of Response to Oral Octreotide Capsules in Comparison to Injectable Somatostatin Receptor Ligands
M. Fleseriu, A. Dreval, Yulia G. Pokramovich, I. Bondar +15 more
2021Journal of the Endocrine Society4 citations Open access
Semantic Scholar
Mentorship in academic medicine: truth is in the eye of the beholder
M. Fleseriu, D. Lim
2023Nature Reviews Endocrinology3 citations Open access
Semantic Scholar
Symptoms at presentation in conservatively managed patients with non-functioning pituitary adenomas
A. J. Han, M. Fleseriu, E. Varlamov
2023HORMONES3 citations
Semantic Scholar
Addition of Cabergoline to Oral Octreotide Capsules May Improve Biochemical Control in Patients With Acromegaly Who Are Inadequately Controlled With Monotherapy
M. Fleseriu, A. Dreval', Yulia G. Pokramovich, I. Bondar +15 more
2021Journal of the Endocrine Society3 citations Open access
Semantic Scholar
Glucocorticoid Receptor Antagonism as a New “Remedy” for Insulin Resistance—Not There Yet!
E. Varlamov, J. Purnell, M. Fleseriu
2021Journal of Clinical Endocrinology and Metabolism3 citations Open access
Semantic Scholar
Lights or shadows, a promising future for positron emission tomography in pituitary tumors: a systematic review
S. Chiloiro, Carmelo Caldarella, Alessandra Vicari, Simone Antonio De Sanctis +12 more
2025Reviews in Endocrine & Metabolic Disorders2 citations
Semantic Scholar
SAT622 Matched Physician- And Patient-reported Responses Of Acromegaly Symptom Control: Comparisons From The Macro Registry
E. Geer, Wen-Yu Huang, M. B. Gordon, Kevin Choong Ji Yuen +9 more
2023Journal of the Endocrine Society2 citations Open access
Semantic Scholar
Individualized acromegaly treatment: Is stereotactic radiation therapy changing the paradigm?
Winnie Liu, M. Fleseriu
2022Frontiers in Endocrinology2 citations Open access
Semantic Scholar
Response to Letter to the Editor From Asa and Mete: “Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease”
F. Langlois, E. Varlamov, M. Fleseriu
2022Journal of Clinical Endocrinology and Metabolism2 citations Open access
Semantic Scholar
Abstract #1040637: Effect of Osilodrostat on Clinical signs, Physical Features and Health-related Quality of Life (HRQoL) by Degree of mUFC Control in Patients with Cushing’s Disease (CD): Results from the LINC3 Study
R. Pivonello, M. Fleseriu, J. Newell-Price, A. Shimatsu +8 more
20212 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Melmed×12
Invite
S. Melmed — researcher profile on SciRah
M. Molitch×9
Invite
M. Molitch — researcher profile on SciRah
E. Varlamov×9
Invite
E. Varlamov — researcher profile on SciRah
B. Biller×9
Invite
B. Biller — researcher profile on SciRah

×8

Invite

N. Biermasz — researcher profile on SciRah

Invite

A. Giustina — researcher profile on SciRah

R. Pivonello×8

Invite

R. Pivonello — researcher profile on SciRah

A. Pedroncelli×6

Invite

A. Pedroncelli — researcher profile on SciRah

J. Newell-Price×5

Invite

J. Newell-Price — researcher profile on SciRah

Invite

I. Shimon — researcher profile on SciRah

Invite

G. Vila — researcher profile on SciRah

Invite

G. Raverot — researcher profile on SciRah